Head-to-head comparisons of medication uses, side effects, warnings, and more.
Breo ellipta (fluticasone furoate / vilanterol)
Symbicort (budesonide / formoterol)
Breo ellipta (fluticasone furoate / vilanterol)
Symbicort (budesonide / formoterol)
Summary of Breo Ellipta vs. Symbicort
Summary for Inhaled corticosteroid / LABA
Prescription only
Breo Ellipta (fluticasone furoate / vilanterol) is a maintenance inhaler used every day to help manage asthma and chronic obstructive pulmonary disease (COPD). It's a combination of two medications: fluticasone, a corticosteroid that reduces swelling in your lungs, and vilanterol, a long-acting beta agonist (LABA) that helps relax your airways. The typical dose is one puff by mouth once a day. Breo Ellipta (fluticasone furoate / vilanterol) isn't for sudden breathing problems or asthma attacks. Side effects include oral thrush, sore throat, and headache.
Summary for Inhaled corticosteroid / LABA
Prescription only
Symbicort (budesonide / formoterol) is a combination inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two medications: budesonide, a steroid, and formoterol, a long-acting beta-agonist (LABA). Both medications work together to reduce inflammation in the lungs and open up your airways. The typical dose is two puffs by mouth twice a day, usually about 12 hours apart. Common side effects include common cold symptoms, headache, and sore throat.
Indications of Breo Ellipta vs. Symbicort
Indications for
•Asthma - in adults and children 5 years and older